Online first
Case report
Published online: 2024-08-13

open access

Page views 7
Article views/downloads 2
Get Citation

Connect on Social Media

Connect on Social Media

Development of granulomatosis with polyangiitis in the patient with chronic myeloid leukemia: a case report and a short review of literature

Martyna Kuczyńska1, Monika Bultrowicz1, Aleksandra Gąsiorek1, Klaudia Palka1, Robert Pieczyrak2, Przemysław Kotyla2, Eugeniusz Józef Kucharz1

Abstract

The association of granulomatosis with polyangiitis (GPA), a form of antineutrophil cytoplasmic antibodies-associated vasculitis (AAV), with neoplastic disease was reported. Most of the described cases are malignancies that develop in patients after long-term vasculitis medication.

The purpose of this paper is to review a rare case of the development of GPA in a patient suffering for more than a decade from chronic myeloid leukemia (CML). Such an association was a challenge for differential diagnosis because it had been initially considered a transition to the accelerated phase of CML or the development of secondary malignancy. Finally, a diagnosis of GPA was established, and medication with cyclophosphamide and subsequently with rituximab was administered. Such management, together with the continuation of medication against CML, led to significant improvement.

The possible associations between vasculitis and malignancy and their clinical implications were discussed.

From the point of view of clinical practice, it is important to remember that a diagnosis of a malignant disorder does not exclude the occurrence or new development of an autoimmune disease. Moreover, the symptoms and signs of both maladies may be akin, and an in-depth differential diagnosis is needed.

Article available in PDF format

View PDF Download PDF file

References

  1. Ahn SS, Lee SW. Management of antineutrophil cytoplasmic antibody-associated vasculitis: a review of recent guidelines. J Rheum Dis. 2023; 30(2): 72–87.
  2. Jennette JC, Falk RJ, Bacon PA, et al. 2012 Revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum. 2012; 65(1): 1–11.
  3. Heijl C, Westman K, Höglund P, et al. Malignancies in Patients with Antineutrophil Cytoplasmic Antibody-associated Vasculitis: A Population-based Cohort Study. J Rheumatol. 2020; 47(8): 1229–1237.
  4. Sun XJ, Li ZY, Chen M. Pathogenesis of anti-neutrophil cytoplasmic antibody-associated vasculitis. Rheumatol Immunol Res. 2023; 4(1): 11–21.
  5. Knight A, Askling J, Ekbom A. Cancer incidence in a population-based cohort of patients with Wegener's granulomatosis. Int J Cancer. 2002; 100(1): 82–85.
  6. Faurschou M, Sorensen I, Mellemkjaer L, et al. Malignancies in Wegener’s granulomatosis: incidence and relation to cyclophosphamide therapy in a cohort of 293 patients. J Rheumatol. 2008; 35: 100–105.
  7. Mahr A, Heijl C, Le Guenno G, et al. ANCA-associated vasculitis and malignancy: current evidence for cause and consequence relationships. Best Pract Res Clin Rheumatol. 2013; 27(1): 45–56.
  8. Ahn SS, Han M, Yoo J, et al. Risk of Cancers in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis: Results from the Korea National Health Insurance Claims Database 2010-2018. J Clin Med. 2019; 8(11).
  9. Knight A, Hjorton K, Sundström C, et al. Leukemia and myelodysplastic syndrome in granulomatosis with polyangiitis: subtypes, clinical characteristics, and outcome. J Rheumatol. 2015; 42(4): 690–694.
  10. Emmi G, Bettiol A, Gelain E, et al. Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis. Nat Rev Rheumatol. 2023; 19(6): 378–393.
  11. Folci M, Ramponi G, Shiffer D, et al. ANCA-Associated Vasculitides and Hematologic Malignancies: Lessons from the Past and Future Perspectives. J Immunol Res. 2019; 2019: 1732175.
  12. Bîrluţiu V, Rezi EC, Bîrluţiu RM, et al. A rare association of chronic lymphocytic leukemia with c-ANCA-positive Wegener's granulomatosis: a case report. World J Surg Oncol. 2016; 14: 145.
  13. Racanelli V, Prete M, Minoia C, et al. Rheumatic disorders as paraneoplastic syndromes. Autoimmun Rev. 2008; 7(5): 352–358.
  14. Hamidou MA, El Kouri D, Audrain M, et al. Systemic antineutrophil cytoplasmic antibody vasculitis associated with lymphoid neoplasia. Ann Rheum Dis. 2001; 60(3): 293–295.
  15. Miyata KN, Siddiqi NA, Kiss LP, et al. Antineutrophil cytoplasmic antibody-positive pauci-immune glomerulonephritis associated with mantle cell lymphoma. Clin Nephrol Case Stud. 2017; 5: 9–15.
  16. Wills Sanín B, Bolivar YR, Carvajal JJ, et al. Polyangiitis with granulomatosis as a paraneoplastic syndrome of B-cell lymphoma of the lacrimal gland. Case Rep Hematol. 2014; 2014: 713048.
  17. Yang TH, St John LS, Garber HR, et al. Membrane-Associated Proteinase 3 on Granulocytes and Acute Myeloid Leukemia Inhibits T Cell Proliferation. J Immunol. 2018; 201(5): 1389–1399.
  18. Sumichika Y, Yokose K, Sato S, et al. Development of Acute Promyelocytic Leukemia in a Patient with Granulomatosis with Polyangiitis: A Case Report. Tohoku J Exp Med. 2023; 259(2): 107–112.